Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

Hutton DW, Tan D, So SK, Brandeau ML.

Ann Intern Med. 2007 Oct 2;147(7):460-9.

PMID:
17909207
2.

Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective.

Ho AM, Nelson EA, Walker DG.

Arch Dis Child. 2008 Jan;93(1):52-8. Epub 2007 Sep 12.

PMID:
17855438
3.

Hepatitis B in China.

Liu J, Fan D.

Lancet. 2007 May 12;369(9573):1582-3. No abstract available.

PMID:
17499584
4.

Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 May 11;56(18):441-5.

5.

Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience.

Maluf DG, Stravitz RT, Williams B, Cotterell AH, Mas VR, Heuman D, Luketic V, Shiffman ML, Sterling R, Posner MP, Fisher RA.

Transplant Proc. 2007 Jan-Feb;39(1):153-9.

PMID:
17275495
6.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

7.

Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India.

Shivananda, Somani V, Srikanth BS, Mohan M, Kulkarni PS.

Clin Vaccine Immunol. 2006 Jun;13(6):661-4.

8.

Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation.

Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG.

Liver Transpl. 2006 May;12(5):801-7.

9.

[A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old].

Liang XF, Chen YS, Wang XJ, He X, Chen LJ, Wang J, Lin CY, Bai HQ, Yan J, Cui G, Yu JJ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Sep;26(9):655-8. Chinese.

PMID:
16471211
10.

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH; REVEAL-HBV Study Group.

JAMA. 2006 Jan 4;295(1):65-73.

PMID:
16391218
11.

Progress in the control of hepatitis B infection in the Western Pacific Region.

Clements CJ, Baoping Y, Crouch A, Hipgrave D, Mansoor O, Nelson CB, Treleaven S, van Konkelenberg R, Wiersma S.

Vaccine. 2006 Mar 15;24(12):1975-82. Epub 2005 Dec 5. Review.

PMID:
16361001
12.

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.

Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.

J Infect Dis. 2005 Nov 15;192(10):1720-6. Epub 2005 Oct 14.

PMID:
16235169
13.

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S133-45.

PMID:
16088797
14.

Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression.

Lin X, Robinson NJ, Thursz M, Rosenberg DM, Weild A, Pimenta JM, Hall AJ.

J Gastroenterol Hepatol. 2005 Jun;20(6):833-43.

PMID:
15946129
15.

Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis.

Kanwal F, Gralnek IM, Martin P, Dulai GS, Farid M, Spiegel BM.

Ann Intern Med. 2005 May 17;142(10):821-31.

PMID:
15897532
16.

The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma.

Pierie JP, Muzikansky A, Tanabe KK, Ott MJ.

Ann Surg Oncol. 2005 Jul;12(7):552-60. Epub 2005 May 9.

PMID:
15889217
17.

Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.

Hu RH, Ho MC, Wu YM, Yu SC, Lee PH.

Clin Transplant. 2005 Apr;19(2):175-80.

PMID:
15740552
18.

A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.

Chan HL, Leung NW, Hui AY, Wong VW, Liew CT, Chim AM, Chan FK, Hung LC, Lee YT, Tam JS, Lam CW, Sung JJ.

Ann Intern Med. 2005 Feb 15;142(4):240-50.

PMID:
15710957
19.

Cost of chronic hepatitis B infection in China.

Zhiqiang G, Zhaohui D, Qinhuan W, Dexian C, Yunyun F, Hongtao L, Iloeje UH.

J Clin Gastroenterol. 2004 Nov-Dec;38(10 Suppl 3):S175-8.

PMID:
15602167
20.

A cost comparison of management of chronic hepatitis B and its associated complications in Hong Kong and Singapore.

Li SC, Ong SC, Lim SG, Yeoh KG, Kwong KS, Lee V, Lee W, Lau J, Wong I, Kung N, Leung WT, Chan HL, Chan FK, Sung JJ, Lee KK.

J Clin Gastroenterol. 2004 Nov-Dec;38(10 Suppl 3):S136-43. Erratum in: J Clin Gastroenterol. 2005 Feb;39(2):176.

PMID:
15602161

Supplemental Content

Support Center